These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27810441)

  • 21. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates.
    Diala I; Murao S; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
    Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
    Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-Albumin Nanoparticles (LAN) for Therapeutic Delivery of Antisense Oligonucleotide against HIF-1α.
    Li H; Quan J; Zhang M; Yung BC; Cheng X; Liu Y; Lee YB; Ahn CH; Kim DJ; Lee RJ
    Mol Pharm; 2016 Jul; 13(7):2555-62. PubMed ID: 27253378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells.
    Fimmel S; Saborowski A; Orfanos CE; Zouboulis CC
    Horm Res; 2000; 54(5-6):306-11. PubMed ID: 11595823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuning G-Quadruplex Nanostructures with Lipids. Towards Designing Hybrid Scaffolds for Oligonucleotide Delivery.
    Grijalvo S; Clua A; Eres M; Gargallo R; Eritja R
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).
    Grijalvo S; Eritja R
    Mol Divers; 2012 May; 16(2):307-17. PubMed ID: 22392648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
    Shiraishi T; Nielsen PE
    Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay.
    Brukner I; Tremblay GA
    Biochemistry; 2000 Sep; 39(37):11463-6. PubMed ID: 10985792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.
    Roth CM
    Biophys J; 2005 Oct; 89(4):2286-95. PubMed ID: 16055530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
    Kaihatsu K; Huffman KE; Corey DR
    Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme.
    Hamel Y; Lacoste J; Frayssinet C; Sarasin A; Garestier T; François JC; Hélène C
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):547-53. PubMed ID: 10215592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.
    Cai Y; Makarova AM; Wengel J; Howard KA
    J Gene Med; 2018 Jul; 20(7-8):e3025. PubMed ID: 29800498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
    Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
    Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
    Lewis JG; Lin KY; Kothavale A; Flanagan WM; Matteucci MD; DePrince RB; Mook RA; Hendren RW; Wagner RW
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3176-81. PubMed ID: 8622909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
    Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation.
    Iversen PL
    Curr Opin Mol Ther; 2001 Jun; 3(3):235-8. PubMed ID: 11497346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agents.
    Shokrzadeh N; Winkler AM; Dirin M; Winkler J
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5758-5761. PubMed ID: 25453815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.